Subjective attitude to risperidone long-acting injectable (RLAI): Results from a long-term Italian study in subjects with schizophrenia or schizoaffective disorder

被引：0
|
作者：
Rossi, A. [1 ]
Bernareggi, M. M. [2 ]
Giustra, M. G. [2 ]
机构：
[1] Univ Laquilo, Dept Expt Med, Laquila, Italy
[2] Janssen Cilag SpA, Risperidone Long Acting Trial Italian Invest, Med Affairs, Milan, Italy
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 50 条
  • [21] Results of direct switching to long-acting injectable risperidone in patients with schizoaffective disorders
    Mohl, A
    Westly, K
    Opjordsmoen, S
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 174 - 174
  • [22] Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
    Lasser, RA
    Bossie, CA
    Zhu, Y
    Gharabawi, G
    Eerdekens, M
    Davidson, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (09) : 898 - 905
  • [23] Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study
    De la Gandara, Jesus
    San Molina, Luis
    Rubio, Gabriel
    Rodriguez-Morales, Alexander
    Hidalgo Borrajo, Rebeca
    Antonio Buron, Jose
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (10) : 1463 - 1474
  • [24] Long-acting risperidone in stable patients with schizoaffective disorder
    Mohl, A
    Westlye, K
    Opjordsmoen, S
    Lex, A
    Schreiner, A
    Benoit, M
    Bräunig, P
    Medori, R
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 22 - 31
  • [25] Haloperidol decanoate and long-acting injectable risperidone: subjective experience of outpatients with schizophrenia
    Dalmotto, M.
    Pirfo, E.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2010, 16 (03): : 299 - 304
  • [26] EFFICACY AND TOLERABILITY AMONG PATIENTS WITH RECENT ONSET SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG-ACTING INJECTABLE (RLAI)
    Napryeyenko, Oleksandr
    Burba, Benjaminas
    Martinez, Guadalupe
    Neznanov, Nikolay
    Fischel, Tsvi
    Bayle, Franck
    Corrivetti, Giulio
    Smeraldi, Enrico
    Rabinowitz, Jonathan
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 496 - 496
  • [27] Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder
    Benabarre, A.
    Castro, P.
    Sanchez-Moreno, J.
    Martinez-Aran, A.
    Salamero, M.
    Murru, A.
    Franco, C.
    Vieta, E.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2009, 37 (03): : 143 - 147
  • [28] RISPERIDONE LONG-ACTING INJECTABLE (RLAI) ADMINISTRATION IN DELTOID MUSCLE ... REALLY IS AN IMPROVEMENT?
    Arques, S.
    Arnau, F.
    Rubio, T.
    Pino, A.
    Iranzo, C.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [29] Long-term treatment with long-acting risperidone in Korean patients with schizophrenia
    Lee, Moon-Soo
    Ko, Young-Hoon
    Lee, Sang-Hoon
    Seo, Yong-Jin
    Kim, Seung-Hyun
    Joe, Sook-Haeng
    han, Cg-Su Han
    Lee, Jung-Ho
    Jung, In-Kwa
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (06) : 399 - 407
  • [30] AN OPEN, RANDOMIZED, CONTROLLED COMPARISON OF LONG-ACTING INJECTABLE RISPERIDONE VS. ORAL OLANZAPINE IN SCHIZOPHRENIA & SCHIZOAFFECTIVE DISORDER
    Keks, Nicholas A.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S5 - S5
12345